A novel class of zinc(II)-based metal complexes, i.e., [Zn 2 (acdp)(μ-Cl)]•2H 2 O (1), [Zn 2 (acdp)(μ-NO 3 )]•2H 2 O (2), and [Zn 2 (acdp)(μ-O 2 CCF 3 )]•2H 2 O (3) (Cl − = chloride; NO 3 − = nitrate; CF 3 CO 2 − = trifluoroacetate) of anthracene-affixed multifunctional organic assembly, H 3 acdp (H 3 acdp = N,N′-bis-[anthracene-2-ylmethyl]-N,N′-bis[carboxymethyl]-1,3-diaminopropan-2-ol), have emerged as promising antibacterial and antibiofilm agents in the domain of medicinal chemistry. Accordingly, complexes 1−3 were synthesized by utilizing H 3 acdp in combination with ZnCl 2 , Zn(NO 3 ) 2 •6H 2 O, and Zn(CF 3 CO 2 ) 2 •H 2 O respectively, in the presence of NaOH at ambient temperature.The complexation between H 3 acdp and Zn 2+ was delineated by a combined approach of spectrophotometric and spectrofluorometric titration studies. The stoichiometry of acdp 3− /Zn 2+ in all three complexes is observed to be 1:2, as confirmed by spectrophotometric/spectrofluorometric titration data. Elemental analysis (C, H, N, Zn), molar conductance, FTIR, UV−vis, and thermoanalytical (TGA/DTA) data were effectively used to characterize these complexes. Besides, the structures of 1−3 were established by density functional theory (DFT) calculation using B3LYP/6-311G, specifying a self-assembled compact geometry with average Zn•••Zn separation of 3.4629 Å. All three zinc complexes exhibited significantly high antibacterial and antibiofilm activity against methicillin-resistant Staphylococcus aureus (MRSA BAA1717). However, complex 1 showed a more recognizable activity than 2 and 3, with minimum inhibitory concentration (MIC) values of 200, 350, and 450 μg/mL, respectively. The antimicrobial activity was tested by employing the minimum inhibitory concentration (MIC) and time-kill assay. The crystal violet (CV) assay and microscopic study were performed to examine the antibiofilm activity. As observed, complexes 1−3 had an effect on the production of extracellular polymeric substance (EPS), biofilm cell-viability, and other virulence factors such as staphyloxanthin and hemolysin production, autoaggregation ability, and microbial cell-surface hydrophobicity. Reactive oxygen species (ROS) generated due to inhibition of staphyloxanthin production in response to 1−3 were also analyzed. Moreover, complexes 1−3 showed an ability to damage the bacterial cell membrane due to accumulation of ROS resulting in DNA leakage. In addition, complexes 1−3 displayed a synergistic/additive activity with a commercially available antibiotic drug, vancomycin, with enhanced antibacterial activity. On the whole, our investigation disclosed that complex 1 could be a promising drug lead and attract much attention to medicinal chemists compared to 2 and 3 from therapeutic aspects.